239 active trials 129 recruiting 7 Phase 3 44 disease areas 17 changes in 30 days
9 trials changed in the last 30 days: 0 stopped, 4 with notable changes, 5 with minor changes only.
Primary completion pushed from Mar 2026 to Nov 2026
Also in this update: Trial status changed: Unknown → Active, Not Recruiting; Completion pushed from Mar 2026 to Mar 2027
University of California, San DiegoPhase 2 NCT06269146 Registry history of NCT06269146 on ClinicalTrials.gov (opens the registry)
Updated
Primary endpoint(s) modified
Also in this update: Phase changed: not applicable → Phase 1; Enrollment increased: 27 → 60 participants
University of California, San DiegoPhase 1 NCT06675240 Registry history of NCT06675240 on ClinicalTrials.gov (opens the registry)
Updated
Results posted: Oct 1, 2026
University of California, San DiegoPhase 2 NCT03082534 Registry history of NCT03082534 on ClinicalTrials.gov (opens the registry)
Updated
Results posted: Sep 24, 2026
University of California, San DiegoNot applicable NCT04713098 Registry history of NCT04713098 on ClinicalTrials.gov (opens the registry)
Updated
Sponsor refiled this as active, not recruiting (was completed)
University of California, San DiegoPhase 1 NCT05224336 Registry history of NCT05224336 on ClinicalTrials.gov (opens the registry)
Updated
Trial completed
Also in this update: Study completion date changed from estimate of Nov 18, 2026 to Aug 18, 2026
University of California, San DiegoPhase 4 NCT03461120 Registry history of NCT03461120 on ClinicalTrials.gov (opens the registry)
Updated
Primary completion moved earlier from Dec 28, 2027 to Jun 27, 2027
Also in this update: Completion moved earlier from Dec 31, 2027 to Jun 30, 2027
University of California, San DiegoPhase 4 NCT07463430 Registry history of NCT07463430 on ClinicalTrials.gov (opens the registry)
Updated
Registry marked status Unknown (sponsor has not verified the record since Mar 2024); last known: Recruiting
University of California, San DiegoNot specified NCT06311123 Registry history of NCT06311123 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since May 2024); last known: Recruiting
University of California, San DiegoNot applicable NCT05559463 Registry history of NCT05559463 on ClinicalTrials.gov (opens the registry)
Changed
Registry verification sweep
Changed
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-09-25 | NCT07840560 Sleep Harmonization Via Bundled Team-Based Interventions in the ICU | Not Yet Recruiting | |
| 2026-09-22 | NCT07834762 Home-Based Randomized Trial of Spaced Transcranial Direct Current Stimulation for… | Not Yet Recruiting | |
| 2026-09-18 | NCT07829055 Effects of Mental Tasks on Breathing Patterns in Adults Using Chronic Opioids vs… | Enrolling by Invitation |
| Early Phase 1 | 6 | |
| Phase 1 | 14 | |
| Phase 1/2 | 8 | |
| Phase 2 | 35 | |
| Phase 2/3 | 1 | |
| Phase 3 | 6 | |
| Phase 4 | 16 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT06865885 | LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL… | Drug Interactions | Recruiting | 2026-07-13 |
| NCT07672015 | Precision Pain Management - A Randomized Clinical Trial Assessing the Efficacy of… | Opioid Consumption, Postoperative | Recruiting | 2026-07-06 |
| NCT06820177 | Tranexamic Acid for Second Trimester Dilation and Evacuation and Bleeding Outcomes | Abortion | Recruiting | 2026-06-15 |
| NCT07282782 | Vancomycin in TKAs | Total Knee Arthroplasty | Recruiting | 2026-06-03 |
| NCT07092527 | Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version | Transgenderism | Recruiting | 2026-01-15 |
| NCT06999577 | The Mechanism Versus PPI Trial | Laryngopharyngeal Reflux | Recruiting | 2025-08-01 |
| NCT06784882 | Continuous Versus Single Injection Adductor Canal Blocks for Outpatient Total Knee… | Acute Postoperative Pain | Recruiting | 2025-06-17 |
| NCT06665971 | Effect of Dupilumab on the Muscle Function of the Esophagus (food Pipe) in Participants… | Eosinophilic Esophagitis (EoE) | Recruiting | 2024-12-11 |
| NCT06385236 | Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping | Moderate to Severe Asthma | Recruiting | 2024-08-19 |
| NCT04849455 | Erector Spinae Plane Block Catheters and Intrathecal Morphine for Hepatic Resection | Hepatic Resection | Recruiting | 2022-06-07 |
| NCT06995352 | Liposomal Bupivacaine Versus Continuous Peripheral Nerve Blocks for Analgesia Following… | Moderate-to-severely Painful Ankle Surgery | Enrolling by Invitation | 2026-09-16 |
| NCT07463430 | Suzetrigine for Non-Mastectomy Breast Surgery | Pain, Acute Postoperative | Enrolling by Invitation | 2026-09-16 |
| NCT07633418 | IO Vancomycin Administration in TKA | Total Knee Arthroplasty | Not Yet Recruiting | 2026-06-08 |
| NCT05690282 | Comparing Perioperative Outcomes in Pain Control | Post-operative Pain | Active, Not Recruiting | 2025-04-24 |
| NCT06063772 | Effect of Treatment of Pre-induction Hypertension on Hemodynamic Stability During… | Hypertension | Not Yet Recruiting | 2024-11-08 |
| NCT04616963 | Emtricitabine/Tenofovir Alafenamide Switch Study for Transgender Individuals for HIV… | Hiv | Active, Not Recruiting | 2023-05-06 |
| Phase 3 | ||||
| NCT06515184 | Coenzyme Q10 for Gulf War Illness: A Replication Study | Gulf War Syndrome | Recruiting | 2026-05-01 |
| NCT06651697 | BladdEr Full OR Empty for Pelvic Radiation Therapy | Pelvic Neoplasm | Recruiting | 2026-02-17 |
| NCT04411225 | Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis | Early Psychosis | Recruiting | 2026-01-08 |
| NCT05443737 | Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult… | Cancer | Recruiting | 2025-12-03 |
| NCT06587490 | Total RadIoTherapy of Oligometastatic caNcerS | Oligometastatic Malignant Solid Neoplasm | Recruiting | 2025-10-14 |
| NCT07211802 | CKM For Safe Use of SGLT2i in Type 1 Diabetes | Type 1 Diabetes (T1D) | Not Yet Recruiting | 2025-10-08 |
| Phase 2/3 | ||||
| NCT06273527 | Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol (R33) | Anxiety Disorders | Recruiting | 2025-10-24 |
| Phase 2 | ||||
| NCT07364071 | Strategic Endocrine Therapy and Targeted Radiotherapy for Prostate Cancer | Prostate Adenocarcinoma | Recruiting | 2026-08-04 |
| NCT06624475 | Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk… | Basal Cell Carcinoma | Recruiting | 2026-07-28 |
Depression (15) · Diabetes (14) · Obesity (10) · Prostate Cancer (8) · Hypertension (6) · Schizophrenia (6) · Type 1 Diabetes (6) · NASH / MASH (5) · Type 2 Diabetes (5) · Psoriatic Arthritis (4)